Holen Sie sich die Stockscreener-App
1.08
1.82%
-0.02
Handel nachbörslich:
1.08
Schlusskurs vom Vortag:
$1.10
Offen:
$1.03
24-Stunden-Volumen:
24,915
Relative Volume:
0.72
Marktkapitalisierung:
$43.57M
Einnahmen:
$13.42M
Nettoeinkommen (Verlust:
$-73.35M
KGV:
-0.5625
EPS:
-1.92
Netto-Cashflow:
$-56.34M
1W Leistung:
+65.14%
1M Leistung:
+8.01%
6M Leistung:
+9.56%
1J Leistung:
-46.00%
1-Tages-Spanne:
$1.00
$1.095
1-Wochen-Bereich:
$0.68
$1.11
52-Wochen-Spanne:
$0.64
$2.14
Barinthus Biotherapeutics Plc Adr Stock (BRNS) Company Profile
Firmenname
Barinthus Biotherapeutics Plc Adr
Sektor
Branche
Telefon
44 (0) 1865 818808
Adresse
UNIT 6-10, ZEUS BUILDING, DIDCOT
Vergleichen Sie BRNS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BRNS
Barinthus Biotherapeutics Plc Adr
|
1.08 | 26.38M | 13.42M | -73.35M | -56.34M | -1.92 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Barinthus Biotherapeutics Plc Adr Stock (BRNS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-25 | Eingeleitet | Jefferies | Buy |
| 2021-05-25 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-05-25 | Eingeleitet | William Blair | Outperform |
| 2021-05-24 | Eingeleitet | H.C. Wainwright | Buy |
Barinthus Biotherapeutics Plc Adr Aktie (BRNS) Neueste Nachrichten
BRNS stock touches 52-week low at $0.8 amid market volatility - Investing.com UK
Dollar General Corp (DG) Shares Up Despite Recent Market Volatility - The News Heater
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Strong Buy: Here's Why - MSN
Exclusive-Mexico's Pemex, billionaire Slim renegotiate deepwater gas project - Yahoo Finance
RBC raises Reckitt Benckiser stock target to £57.00, keeps outperform - MSN
Stocks Generating Improved Relative Strength: Revolution Medicines - MSN
Barinthus Bio shifts focus, cuts workforce to extend cash runway - Investing.com
The big rebrand: Why these 4 biopharmas changed their name this year - PharmaVoice
Barinthus Bio intiates Phase 1 clinical trial of VTP-1000 for treatment of coeliac disease - European Pharmaceutical Manufacturer
Barinthus Biotherapeutics Initiates Phase 1 Clinical Trial of VTP-1000 for the Treatment of Celiac Disease - Investing.com
Mexico Shingles Vaccine Market Size & Outlook, 2023-2030 - Grand View Research
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Benzinga
Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Finanzdaten der Barinthus Biotherapeutics Plc Adr-Aktie (BRNS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.89%
3.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):